Taro Pharmaceutical Industries Ltd's asset turnover ratio, the ratio that measures the ability of Taro Pharmaceutical Industries Ltd's assets to generate revenue, sequentially decreased to 0.27 in the fourth quarter (Mar 31 2023), which does not come as a surprise, as the Taro Pharmaceutical Industries Ltd continue to experience difficult business climate.

Within sector 203 more businesses have achieved higher asset turnover ratio. While ranking the asset turnover ratio, among all other companies, it is fair to say, that the company's position has deteriorated in the fourth quarter 2023 compared to the preceding quarter from 0 to 3555.

Asset Turnover Ratio Definition

Select the Comparisons :

None ▼

Select the Ratio:

Asset Turnover▼

None ▼

Asset Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

TARO Asset Turnover Ratio	(Mar 31 2023) IV. Quarter	0 III. Quarter	0 II. Quarter	0 I. Quarter	(Mar 31 2022) IV. Quarter
Y / Y Asset Change	23.22 %	-11.22 %	-11.22 %	-15.14 %	-21.94 %
Y / Y Revenue Change	2.07 %	-	-	-	2.25 %
Asset Turnover Ratio (TTM)	0.27	-	-	-	0.25
TARO's Total Ranking	# 3555	# 0	# 3514	# 2915	# 0
Seq. Asset Change	0 %	0 %	4.62 %	17.78 %	-27.95 %
Seq. Revenue Change	-	-	-	-	-

Asset Turnover Ratio Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	# 204
Healthcare Sector	# 565
Overall Market	# 3555

Asset Turnover Ratio Statistics
High	Average	Low
3.98	3.08	2.57
(Mar 31 2016)		(Mar 31 2021)

TARO Company Profile • Back to TARO Efficiency Comparisons • Compare TARO Asset Turnover Ratio to its Competitors

Companies with similar Asset Turnover Ratio for the quarter ending Mar 31 2023, within Healthcare Sector	Asset Turnover Ratio	Revenues for 12 Months ending Mar 31 2023	Assets at quarter ending Mar 31 2023
Quest Diagnostics Inc	0.74	$ 9,603.000 Millions	$ 13,041.500 Millions
Staar Surgical Co	0.73	$ 294.719 Millions	$ 401.126 Millions
Alphatec Holdings Inc	0.73	$ 389.044 Millions	$ 529.720 Millions
Carlisle Companies Incorporated	0.73	$ 5,406.500 Millions	$ 7,411.775 Millions
Natera Inc	0.72	$ 867.845 Millions	$ 1,197.361 Millions
Sangui Biotech International Inc	0.72	$ 0.081 Millions	$ 0.112 Millions
Arcturus Therapeutics Holdings Inc	0.72	$ 281.040 Millions	$ 387.973 Millions
Caremax Inc	0.72	$ 667.195 Millions	$ 921.214 Millions
Resmed Inc	0.72	$ 3,993.673 Millions	$ 5,520.786 Millions
Aytu Biopharma Inc	0.72	$ 104.115 Millions	$ 144.069 Millions
Tenet Healthcare Corp	0.72	$ 19,450.000 Millions	$ 26,980.000 Millions
Neurocrine Biosciences Inc	0.72	$ 1,598.500 Millions	$ 2,219.400 Millions
Nevro Corp	0.72	$ 414.850 Millions	$ 576.565 Millions
Iradimed Corporation	0.71	$ 56.468 Millions	$ 79.100 Millions
Merit Medical Systems Inc	0.71	$ 1,173.131 Millions	$ 1,653.083 Millions
Smiledirectclub Inc	0.71	$ 438.874 Millions	$ 618.756 Millions
Silk Road Medical Inc	0.71	$ 150.748 Millions	$ 213.634 Millions
Paragon 28 inc	0.70	$ 192.048 Millions	$ 272.416 Millions
Strata Skin Sciences Inc	0.70	$ 36.687 Millions	$ 52.054 Millions
Kaya Holdings Inc	0.70	$ 0.545 Millions	$ 0.774 Millions
Koru Medical Systems Inc	0.70	$ 29.044 Millions	$ 41.428 Millions
Amphastar Pharmaceuticals Inc	0.70	$ 518.641 Millions	$ 741.514 Millions
Encompass Health Corporation	0.70	$ 4,175.400 Millions	$ 5,985.475 Millions
Lannett Company Inc	0.70	$ 300.247 Millions	$ 431.179 Millions
Davita Inc	0.69	$ 11,665.038 Millions	$ 16,929.603 Millions
Protalix Biotherapeutics inc	0.69	$ 41.141 Millions	$ 59.924 Millions
Tela Bio Inc	0.69	$ 44.197 Millions	$ 64.385 Millions
Msa Safety Inc	0.68	$ 1,595.445 Millions	$ 2,338.096 Millions
Sensus Healthcare Inc	0.68	$ 37.608 Millions	$ 55.310 Millions
3m Company	0.68	$ 31,455.000 Millions	$ 46,287.750 Millions

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.